Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Autobio Diagnostics
Zhengzhou, Henan, Chinaen.autobio.com.cn ↗
- Ownership
- Private
- Employees
- ~6000
- Development stage
- Commercial
01
Overview
Autobio Diagnostics has a broad commercial portfolio of IVD products with over 529 product registration certificates and more than 322 CE-marked products. Their technologies are widely adopted in China and exported to over 100 countries. The company’s SARS-CoV‑2 reagent received NMPA certification[1][4].
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- ImmunoassayMolecular diagnosticsMicrobiology diagnosticsBiochemistry diagnosticsPoint-of-care testing (POCT)Automated chemiluminescence immunoassay analyzers
- Industry
- Molecular Diagnostics
02
Partnerships
International distribution partners across Europe, Asia-Pacific, Middle East
Beyond the preview
Go deeper on Autobio Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Autobio Diagnostics.